Scientists have made remarkable progress in understanding the thousands of genes inside our cells and the link they may have to cancer. Researchers continue to discover patient-specific...

Successfully complete new hire orientation Complete training to gain competency in SA, RxClaims and MSA Toolbox Attend Prime intern activities, such as volunteer opportunities and intern lunch and...

In recent years, there have been significant advances in drug development to identify and target disease-causing genetic mutations.1 In order to achieve disease response, drugs commonly bind to a...

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

Therapy options Keytruda (Pembrolizumab) Adstiladrin (nadofaragene firadenovec-vncg) Anktiva (nogapendekin alfa inbakicept-pmln) + BCG Study KEYNOTE-057, phase 2, open label; 5-year follow-up;...

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend

As the efficacy and cost of these therapies become clear, so is the need for thoughtful managed care strategies, according to Prime Therapeutics thought leaders

Studies aim to highlight the impact of various healthcare strategies and programs on patient outcomes and cost containmenta

References National Cancer Institute. (2020, October 26). Radiopharmaceuticals: radiation therapy enters the molecular age....